35
Views
24
CrossRef citations to date
0
Altmetric
Original

Biological Variation in Serum Lipid Concentrations

Pages 86-91 | Published online: 29 Mar 2011

References

  • Watkin D M, Lawry E Y, Mann G V, Halperin M. A study of serum beta lipoprotein and total cholesterol variability and its relation to age and serum level in adult human subjects. J Clin Invest 1954; 33: 874–883
  • Lipid Research Clinics Program. The lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 25: 1351–374
  • Frick M H, Elo O, Haapa K, et al. The Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidaemia - Safety of treatment, changes in risk factors and incidence of coronary heart disease. N Engl JMed 1987; 317: 1237–1245
  • Report on the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988; 148: 36–39
  • European Atherosclerosis Society Study Group. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J 1987; 8: 77–88
  • Shepherd J, Betteridge D J, Durrington P, et al. Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyper-lipidaemia Association. Br Med J 1987; 295: 1245–1246
  • Bloor W R. Biochemistry of the Fatty Acids and their compounds, the lipids. American Chemical Monograph Series No. 93, NY Reinhold Publishing Corporation. 1943
  • Bang L. Uber Lipamie I. Biochm Ztschr 1918; 90: 383–396
  • Boyd E M. Diurnal variations in plasma lipids. J Biol Chem 1935; 110: 61–75
  • Turner K B, Steiner A A. Along term study of the variation of serum cholesterol in man. J Clin Invest 1939; 18: 397–416
  • Palokeimo J. Seasonal variations of serum lipids in healthy men. Ann Med Exp Biol Fenn 1961; 39(suppl 8)1–88
  • Demacker P NM, Schade P WB, Jansen R PT, Van't Laar A. Intraindividual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans. Atherosclerosis 1982; 45: 259–266
  • Hammond J, Wentz P, Stall B E, et al. Daily variations of lipids and hormones in sera of healthy subjects. Clin Chim Acta 1976; 73: 347–352
  • Hegsted D M, Nicolosi R J. Individual variation in serum cholesterol levels. Proc Natl Acad Sci USA 1987; 84: 6259–6261
  • Groen J, Tjiong B K, Kamminga C E, Willebrands A F. The influence of nutrition, individuality and some other factors including various forms of stress on the serum cholesterol: an experiment of nine months duration in 60 normal human volunteers. Voeding 1952; 13: 556–587
  • Rotterdam E P, Katan M B, Knuiman J I. Importance of time interval between repeated measurements of total or high density lipoprotein cholesterol when estimating an individual's baseline concentrations. Clin Chem 1987; 33: 1913–1915
  • Keys A. Diet and blood cholesterol in population surveys -lessons from analysis of the data from a major survey in Israel. Am J Clin Nulr 1988; 48: 1161–1165
  • Dixon M, Paterson C R. Posture and the composition of plasma. Clin Chem 1978; 24: 824–826
  • Koerselman H B, Lewis B, Pilkington T RE. The effects of venous occlusion on the level of serum cholesterol. J Atheroscler Res 1961; 1: 85–88
  • Durrington P N. Hyperlipidaemia: Diagnosis and Management. Wright, London 1989; 308
  • Laboratory Methods Committee of the Lipid Research Clinics Program. Cholesterol and triglyceride concentrations in serum/plasma pairs. Clin Chem 1977; 23: 60–63
  • Blank D W, Hoeg J M, Kroll M H, Ruddell M E. The method of determination must be considered in interpreting blood cholesterol levels. JAMA 1986; 256: 2767–2770
  • Baggio G, Fellin R, Baiocchi M R, et al. Relationship between triglyceride-rich lipoprotein (chylomicrons and VLDL) and HDL2 and HDL3 in the post prandial phase in humans. Atherosclerosis 1980; 37: 271–276
  • Miettinen T A. Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins. J Lipid Res 1982; 23: 466–473
  • Low-Beer T S, Wicks A CB, Heaton K W, et al. Fluctuations of serum and bile lipid concentrations during the menstrual cycle. Br Med J 1977; i: 1568–1570
  • Barclay M, Barclay R K, Skipski V P, et al. Fluctuations in human serum lipoproteins during the normal menstrual cycle. Biochem J 1965; 96: 205–212
  • Taylor G O, Akande E O. Serum lipids in pregnancy and socioeconomic status. Br J Obstet Gynaecol 1975; 82: 297–302
  • Svanborg A, Vikrot O. Plasma lipid fractions, including individual phospholipids at various stages of pregnancy. Acta Med Scand 1975; 178: 615–630
  • Warth M R, Arky R A, Knopp R H. Lipid metabolism in pregnancy III Altered lipid composition in intermediate, very low, low and high density lipoprotein fractions. J Clin Endocrinol Metab 1975; 41: 649–655
  • Hillman L, Schonfeld G, Miller J P, et al. Apolipoproteins in human pregnancy. Metabolism 1975; 24: 943–952
  • Bengtsson C, Tibblin E, Blohome G, Gustafson A. Serum cholesterol and serum triglycerides in middle-aged women. The study of women in Gotenborg 1968–69. Scand J Clin Lab Invest 1974; 34: 61–66
  • Boniface D R. Seasonal variation of cholesterol in the clofibrate trial data. Report on Project for practical part of MSc Statistics. London School of Economics. 1972
  • Heyden S. Epidemiological data on dietary fat intake and atherosclerosis with an appendix on possible side effects. The Role of Fats in Human Nutrition, A J Vergroesen. Academic Press, London 1975; 45–113
  • Jansen R G, Gander G W, Sampugna J. J Dairy Sci 1962; 45: 329
  • Castelli W P, Doyle J T, Gordon T, et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet 1977; ii: 153–155
  • Enger S C, Stromma S B, Refsum H E. High density lipoprotein cholesterol, total cholesterol and triglycerides in serum after a single exposure to prolonged heavy exercise. Scand J Clin Lab Invest 1980; 40: 341–345
  • Ballantyne D, Clark R S, Ballantyne F E. The effect of physical training on plasma lipids and lipoproteins. Clin Cardiol 1981; 4: 1–4
  • Farrell P A, Barboriak J. The time course of alterations in plasma lipid and lipoprotein concentrations during eight weeks of endurance training. Atherosclerosis 1980; 37: 231–238
  • Garrison R J, Kannel W B, Feinleib M, et al. Cigarette smoking and HDL cholesterol. The Framingham Offspring Study. Atherosclerosis 1978; 30: 17–25
  • Rifkind B M, Segal P. Lipid Research Clinics Program reference values of hyperlipidaemia and hypolipidaemia. J A MA 1983; 250: 1869–1872
  • Fyfe T, Baxter R H, Cochran K M, Booth E M. Plasma-lipid changes after myocardial infarction. Lancet 1971; ii: 997–1001
  • Avogaro P, Bittolo Bon G, Cazzolato G, et al. Variations in apolipoproteins B and Al during the course of myocardial infarction. Eur J Clin Invest 1978; 8: 121–129
  • Ryder R EJ, Hayes T M, Mulligan I P, et al. How soon after myocardial infarction should plasma lipid values be assessed. Br Med J 1984; 289: 1651–1653
  • Durrington P N, Hunt L, Ishola M, et al. Serum apolipoprotein AI and B and lipoproteins in middle-aged men with and without previous myocardial infarction. Br Heart J 1986; 56: 206–212
  • Schatzkin A, Hoover R N, Taylor P R, et al. Serum cholesterol and cancer in the NH ANESI epidemiologic followup study. Lancet 1987; ii: 298–302
  • Nestel P J. Cholesterol metabolism in anorexia nervosa and hypercholesterolaemia. J Clin Endocrinol Metab 1974; 38: 325–328
  • Durrington P N, Brownlee W C, Large D M. Short-term effects of β-adrenoreceptor-blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men. Clin Sci 1985; 69: 713–719
  • Durrington P N, Roberts C JC, Jackson L, et al. Effects of phenobarbitone on plasma lipids in normal subjects. Clin Sci Mol Med 1976; 50: 349–353
  • Pelkonen R, Fogelholm R, Nikkila E A. Increase in serum cholesterol during phenytoin treatment. Br Med J 1987; iv: 85
  • Nikkila E A, Kaste M, Ehnholm C, Viikari J. Increase of serum high-density-lipoprotein in phenytoin users. Br Med J 1978; ii: 99
  • Durrington P N. Effect of phenobarbitone on plasma apolipoprotein B and plasma high-density-lipoprotein cholesterol in normal subjects. Clin Sci 1979; 56: 501–504
  • Luoma P V, Sotaniemi E A, Pelkonen R O, et al. Plasma high density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver. Eur J Clin Pharmacol 1982; 23: 275–282
  • Carlson L A, Komodin-Hedman B. Hyperalpha-lipoproteinaemia in men exposed to chlorinated hydrocarbon pesticides. Acta Med Scand 1972; 192: 29–32
  • Fraser H S, Bulpih C J, Kahn C, et al. Factors affecting antipyrine metabolism in West African villagers. Clin Pharm Ther 1976; 20: 369–376
  • Manninen V, Elo O, Frick H, et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988; 260: 641–651
  • Abbott R D, Carroll R J. Interpreting multiple logistic regression coefficients in prospective observational studies. Am J Epidemiol 1984; 119: 830–836
  • Castelli W P. The triglyceride issue: a view from Framing-ham. Am Heart J 1986; 112: 432–437

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.